Cutaneous Autoimmunity

References

• Fine J-D. The skin basement membrane zone. Advances in Dermatology, JP Callen, MV Dahl, LE Golitz, JE Rasmussen, SJ Stegman. Year Book, Chicago 1987; Vol. 2: 283–304
   Google Scholar
• Gorbsky G, Cohen S, Steinberg M S. Desmosomal antigens are not recognised by the majority of pemphigus autoimmune sera. J Invest Dermatol 1983; 80: 475–80
   PubMed Web of Science ®Google Scholar
• Hadi S M, Barnetson RStC, Gawkrodger D J, Saxena U, Bird P, Merrett T G. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid. Dermatologica 1988; 176: 6–17
   PubMedGoogle Scholar
• Logan R A, Bhogal B, Das A K, McKee P M, Black M M. Localization of bullous pemphigoid antibody—an indirect immunofluorescence study of 228 cases using a split-skin technique. Br J Dermatol 1987; 117: 471–8
   PubMed Web of Science ®Google Scholar
• Stanley J R, Woodley D T, Katz S I. Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol 1984; 82: 108–11
   PubMed Web of Science ®Google Scholar
• Fine J D, Neises G R, Katz S I. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. J Invest Dermatol 1984; 82: 39–43
   PubMed Web of Science ®Google Scholar
• Holmes R C, Black M M. The fetal prognosis in pemphigoid gestationis (herpes gestationis). Br J Dermatol 1984; 110: 67–72
   PubMed Web of Science ®Google Scholar
• Roscoe J T, Mutasim D, Labib R S. Autoantibodies from a patient with herpes gestationis identify a bullous pemphigoid antigen by immunoblotting. Clin Res 1985; 33: 773A
   Google Scholar
• Palestine R F, Kossard S, Dicken C H. Epiderolysis bullosa acquisita: a heterogeneous disease. J Am Acad Dermatol 1981; 5: 43–53
   PubMed Web of Science ®Google Scholar
• Woodley D, Sauder D, Talley M J, Silver M, Grotendorst D, Quarnstrom E. Localization of basement membrane components after dermal-epidermal junction separation. J Invest Dermatol 1983; 81: 149–53
   PubMed Web of Science ®Google Scholar
• Woodley D T, Burgeson R E, Lunstrum G, Bruckner-Tuderman L, Reese M J, Briggaman R A. The epidermolysis bullosa acquisita antigen is the globular carboxyi terminus of type VII procollagen. J Clin Invest 1988; 81: 638–7
   Web of Science ®Google Scholar
• Rosenberg F R, Sanders S., Nelson C T. Pemphigus. A 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976; 112: 962–70
   PubMed Web of Science ®Google Scholar
• Stanley J R, Yaar M, Hawley-Nelson P, Katz S I. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 1982; 70: 281–8
   PubMed Web of Science ®Google Scholar
• Maize J C, Dobson RL., Provost T T. Pemphigus and myasthenia gravis. Arch Dermatol 1975; 111: 1334–9
   PubMedGoogle Scholar
• Gawkrodger D J, Blackwell J N, Gilmour H M, Rifkind E A, Heading R C, Barnetson RStC. Dermatitis herpetiformis: diagnosis, diet and demography. Gut 1984; 25: 151–7
   PubMed Web of Science ®Google Scholar
• Zone J J, LaSalle B A, Provost T T. Induction of IgA circulating immune complexes after wheat feeding in dermatitis herpetiformis patients. J Invest Dermatol 1982; 78: 375–80
   PubMed Web of Science ®Google Scholar
• White A G, Barnetson RStC, Da Costa J AG, McClelland D BL. The incidence of HL-A antigens in dermatitis herpetiformis. Br J Dermatol 1973; 89: 133–6
   PubMed Web of Science ®Google Scholar
• Fraser N G. Autoantibodies in dermatitis herpetiformis. Br J Dermatol 1970; 83: 609–13
   PubMedGoogle Scholar
• Davies M G, Marks R, Nuki G. Dermatitis herpetiformis—a skin manifestation of a generalized disturbance in immunity. Quart J Med 1978; 186: 221–48
   Google Scholar
• Weetman A P, Burrin J M, Mackay D, Leonard J N, Griffiths C EM, Fry L. The prevalence of thyroid autoantibodies in dermatitis herpetiformis. Br J Dermatol 1988; 118: 377–83
   PubMed Web of Science ®Google Scholar
• Lerner A B, Nordlund J J. Vitiligo. What is it? Is it important. JAMA 1978; 239: 1183–7
   PubMed Web of Science ®Google Scholar
• Brostoff J, Bor S, Feiwel M. Autoantibodies in patients with vitiligo. Lancet 1969; 2: 177–8
   PubMed Web of Science ®Google Scholar
• Betterle C, Del Prete G F, Peserico A, Bersani G, Garacciolo F, Trisotto Poggi A. F. Autoantibodies in vitiligo. Arch Dermatol 1976; 112: 1328
   PubMedGoogle Scholar
• Hertz K C, Gazze L A, Kirkpatrick C H, Katz SI. Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med 1977; 297: 634–7
   PubMed Web of Science ®Google Scholar
• Naughton G K, Eisinger M, Bystryn J-C. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983; 81: 540–2
   PubMed Web of Science ®Google Scholar
• Frank S B, Cohen H J. The halo nevus. Arch Dermatol 1964; 89: 367–73
   PubMedGoogle Scholar
• Messenger A G, Slater D N, Bleehen S S. Alopecia areata: alterations in the hair growth cycle and correlation with follicular pathology. Br J Dermatol 1986; 114: 337–47
   PubMed Web of Science ®Google Scholar
• Galbraith G MP, Thiers B H, Vasily D B, Fridenberg H H. Immunological profiles in alopecia areata. Br J Dermatol 1984; 110: 163–70
   PubMed Web of Science ®Google Scholar
• Cunliffe W C, Hall R, Stevenson C J, Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969; 81: 877–81
   PubMed Web of Science ®Google Scholar
• Friedmann P S. Alopecia areata and autoimmunity. Br J Dermatol 1981; 105: 153–7
   PubMed Web of Science ®Google Scholar
• Graham-Brown R AC, Sarkany I, Sherlock S. Lichen planus and primary biliary cirrhosis. Br J Dermatol 1982; 106: 699–703
   PubMed Web of Science ®Google Scholar
• Harrington C I, Dunsmore I R. An investigation into the incidence of autoimmune disorders in patients with lichen sclerosis and atrophicus. Br J Dermatol 1981; 104: 563–6
   PubMed Web of Science ®Google Scholar
• Rowell N R. Lupus erythematosus, scleroderma and dermatomyositis. The collagen or connective tissue diseases. Textbook of Dermatology 4th ed., A Rook, DS Wilkinson, FJG Ebling, RH Champion, JL. Burton. Blackwell, Oxford 1986; 1281–1392
   Google Scholar
• Burge S M, Frith P A, Wojnarowska F, Juniper R P, Millard P. Mucosal involvement in lupus erythematosus. Br J Dermatol 1988; 33: 26–7, 119 Suppl.
   Google Scholar
• Sontheimer R D, Thomas J R, Gilliam J N. Subacute cutaneous lupus ervthematosus. Arch Dermatol 1979; 115: 1409–15
   PubMed Web of Science ®Google Scholar
• Gawkrodger D J, Bevendge G W. Neonatal lupus erythematosus in four successive sublings. Br J Dermatol 1984; 111: 683–7
   PubMed Web of Science ®Google Scholar
• Bell D A, Maddison P J. Serological subsets in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 1268–73
   PubMed Web of Science ®Google Scholar
• Catoggio L J, Bernstein R M, Black C M, Hughes G RV, Maddison P J. Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis 1983; 42: 23–7
   PubMed Web of Science ®Google Scholar
• Jablonska S, Chorzelski T, Maciejowska E. The scope and limitations of the immunofluorescence method in the diagnosis of lupus erythematosus. Br J Dermatol 1970; 83: 242–7
   PubMed Web of Science ®Google Scholar
• Dawkins R L, Mastaglia F L. Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med 1973; 288: 434–8
   PubMed Web of Science ®Google Scholar